<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Gastritis: Etiology and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Gastritis: Etiology and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Gastritis: Etiology and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark Feldman, MD, MACP, AGAF, FACG</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Pamela J Jensen, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">J Thomas Lamont, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 29, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Gastric inflammatory diseases can be broadly categorized into gastritis and gastropathy based on the presence or absence of associated mucosal inflammation due to gastric injury. Gastritis is predominantly an inflammatory process, while the term gastropathy denotes a gastric mucosal disorder with minimal to no inflammation. Although the term "gastritis" is often used to describe endoscopic or radiologic characteristics of abnormal-appearing gastric mucosa, a diagnosis of gastritis requires histopathologic evidence of inflammation.</p><p>This topic will review the etiology, classification, and diagnosis of gastritis. Specific causes of acute and chronic gastritis and gastropathy are presented in detail separately. (See  <a class="medical medical_review" href="/d/html/36.html" rel="external">"Acute hemorrhagic erosive gastropathy and reactive gastropathy"</a> and  <a class="medical medical_review" href="/d/html/31.html" rel="external">"Acute and chronic gastritis due to Helicobacter pylori"</a> and  <a class="medical medical_review" href="/d/html/30.html" rel="external">"Metaplastic (chronic) atrophic gastritis"</a> and  <a class="medical medical_review" href="/d/html/9.html" rel="external">"Granulomatous gastritis"</a>.)</p><p class="headingAnchor" id="H2892835935"><span class="h1">DEFINITIONS</span></p><p class="headingAnchor" id="H1126902901"><span class="h2">Gastropathy</span><span class="headingEndMark"> — </span>Epithelial cell damage and regeneration with minimal or no associated inflammation is termed "gastropathy."</p><p class="headingAnchor" id="H2031682208"><span class="h2">Gastritis</span><span class="headingEndMark"> — </span>The term "gastritis" is used to denote inflammation associated with gastric mucosal injury.</p><p class="headingAnchor" id="H3352282798"><span class="h1">ETIOLOGY AND CLASSIFICATION</span><span class="headingEndMark"> — </span>Gastritis is usually caused by infectious agents (eg, <em>Helicobacter pylori</em>) or is immune mediated, although in many cases the cause of the gastritis is unknown.</p><p>Gastritis has been classified by time course (acute versus chronic), proposed pathophysiology and histologic features, and etiology  (<a class="graphic graphic_table graphicRef91372" href="/d/graphic/91372.html" rel="external">table 1</a>) [<a href="#rid1">1</a>]. Although several classifications have been proposed, there is no universally accepted classification of gastritis [<a href="#rid1">1-13</a>]. Classification of gastritis remains controversial because of gaps in knowledge of etiology and pathogenesis, variation in nomenclature, and the frequent coexistence of more than one type in an individual patient. Furthermore, the entities overlap morphologically, and so some conditions are classified by etiology and others by morphologic pattern. Most classification systems distinguish acute, short-term disease from chronic, long-term disease. The terms acute and chronic are also used to describe the type of inflammatory cell infiltrate. Acute inflammation is represented by neutrophilic infiltration, while chronic inflammation is characterized by a mixture of mononuclear cells, chiefly lymphocytes, plasma cells, and macrophages.</p><p>The most comprehensive and widely used classification system, the updated Sydney system, classifies gastritis on the basis of the morphology, topography, and possible etiology into acute, chronic, and special (or distinctive) [<a href="#rid5">5</a>]. Special forms of gastritis include those without a clear etiology and gastropathies. Chronic gastritis is categorized as nonatrophic or atrophic. However, the updated Sydney system does not yield actionable prognostic information concerning the risk of gastric cancer in patients with chronic atrophic gastritis and intestinal metaplasia. (See  <a class="medical medical_review" href="/d/html/30.html" rel="external">"Metaplastic (chronic) atrophic gastritis"</a>.)</p><p>In patients with chronic atrophic gastritis and intestinal metaplasia, the Operative Link for Gastritis Assessment (OLGA) and the Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) systems for staging aid in prediction of cancer risk  (<a class="graphic graphic_table graphicRef116254" href="/d/graphic/116254.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef121370" href="/d/graphic/121370.html" rel="external">table 3</a>). Some experts suggest using a combination of both to stage chronic atrophic gastritis and intestinal metaplasia. The OLGA/OLGIM staging systems incorporate histologic phenotypes with extent of disease to aid in prediction of cancer risk [<a href="#rid8">8-10</a>]. High-stage disease (OLGA/OLGIM III/IV) are associated with a high risk of gastric cancer. The OLGIM staging system shows less inter-observer variability compared with OLGA but may be less sensitive in identifying high-risk gastritis [<a href="#rid8">8,9,11,12</a>]. (See  <a class="medical medical_review" href="/d/html/30.html" rel="external">"Metaplastic (chronic) atrophic gastritis", section on 'Histologic staging of severity'</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of gastritis is usually established on biopsy specimens from patients undergoing upper endoscopy for evaluation of often unrelated upper abdominal symptoms.</p><p class="headingAnchor" id="H3331931258"><span class="h2">Endoscopy and gastric mucosal biopsy</span><span class="headingEndMark"> — </span>Endoscopic information should include a brief narrative and/or endoscopic pictures of focal lesions (eg, thickened folds, polyps, masses, erosions, or ulcers) and abnormal-looking areas. Communication between the endoscopist and pathologist is necessary to optimize the interpretation of the biopsy specimens.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Endoscopic features</strong> – Endoscopic features of gastritis include erythema, mucosal erosions, the absence of rugal folds, and the presence of visible vessels. However, these features have a low sensitivity and there is significant inter-observer variability for some features [<a href="#rid14">14</a>]. An illustrative study included 488 adults who were randomly selected from the general population and were screened by gastroscopy and biopsy [<a href="#rid15">15</a>]. The authors evaluated the sensitivity of macroscopic features (including erythema, mucosal erosions, the absence of rugal folds, and the presence of visible vessels) compared with histologic findings. None of these endoscopic findings had sensitivity greater than 57 percent for determining the presence of gastritis or <em>H. pylori</em> infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastric biopsy protocol and</strong> <strong>histology</strong> – Histologic findings of gastritis can vary over a wide spectrum, ranging from epithelial hyperplasia with minimal inflammation to extensive epithelial cell damage with infiltration by inflammatory cells. Accurate histologic assessment of gastritis and gastropathy depends upon optimizing the site and number of biopsy specimens. Magnification endoscopy, if available, may improve the identification of areas to biopsy and may reduce the number of biopsies taken. (See  <a class="medical medical_review" href="/d/html/2646.html" rel="external">"Magnification endoscopy"</a>.)</p><p></p><p class="bulletIndent1">Biopsy site preferences and number vary in clinical practice based on the incidence and risk factors for gastric cancer. However, there is general consensus among experts on the following biopsy approach [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Multiple biopsies of both the corpus and the antrum should be obtained when attempting to evaluate gastritis and establish the etiology (eg, <em>H. pylori</em> or autoimmune gastritis)  (<a class="graphic graphic_figure graphicRef90132" href="/d/graphic/90132.html" rel="external">figure 1</a>). For optimal assessment, one to two biopsies from five biopsy sites are taken (greater and lesser curvature of antrum, greater and lesser curvature of the corpus, and the incisura angularis). This approach is endorsed in the updated Sydney Classification [<a href="#rid5">5</a>]. This systematic approach to biopsy sites is recommended, regardless of symptomatology or endoscopic findings, due to the known lack of correlation with histologic features. Although it is preferable to separate the fundic and antral biopsy sites into separate containers, this is rarely done in practice, and the biopsy sites can usually be differentiated on histology. Of course, if a discrete lesion is seen and biopsied, this must be placed in a separately designated container.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In first-degree relatives of patients with early onset gastric carcinoma (age &lt;45 years), endoscopic evaluation with at least four biopsies from the gastric antrum and corpus is suggested. Multiple biopsies with adequate sampling are necessary for scoring and staging of premalignant lesions in this subgroup of patients [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Normal-appearing mucosa adjacent to the lesional tissue should also be biopsied.</p><p></p><p class="bulletIndent1">The pathologist should include a morphologic classification of the gastritis or gastropathy in the biopsy report, including site(s) of involvement, degree of inflammation (mild, moderate, severe), and presence/absence of intestinal metaplasia. In cases of <em>H. pylori</em> gastritis, the degree of inflammation often correlates with the number of organisms  (<a class="graphic graphic_picture graphicRef139284" href="/d/graphic/139284.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef139285" href="/d/graphic/139285.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef139286" href="/d/graphic/139286.html" rel="external">picture 3</a> and <a class="graphic graphic_table graphicRef80329" href="/d/graphic/80329.html" rel="external">table 4</a>) [<a href="#rid16">16</a>].</p><p></p><p class="headingAnchor" id="H3912719675"><span class="h2">Determining the etiology</span><span class="headingEndMark"> — </span>The etiology of gastritis may be clear based on the clinical history and histopathologic examination of the stomach [<a href="#rid17">17</a>]. However, in other cases, additional testing may be required.</p><p class="headingAnchor" id="H897861708"><span class="h3">History</span><span class="headingEndMark"> — </span>Key elements of the history include relevant predisposing factors/associated conditions (eg, Crohn disease, sarcoidosis, celiac disease).</p><p class="headingAnchor" id="H1520666945"><span class="h3">Duodenal histology if obtained</span><span class="headingEndMark"> — </span>Biopsies of the duodenum may also be helpful for diagnosing some forms of chronic gastritis. As examples, duodenal biopsies may show evidence of Crohn disease in patients with granulomatous gastritis or celiac disease in patients with lymphocytic gastritis. (See  <a class="medical medical_review" href="/d/html/9.html" rel="external">"Granulomatous gastritis", section on 'Etiology'</a>.)</p><p class="headingAnchor" id="H831025490"><span class="h3">Additional tests in selected patients</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Testing for </strong><strong><em>H. pylori</em></strong> – In patients with chronic atrophic gastritis without a clear underlying etiology, hematoxylin and eosin (H&amp;E) plus a second stain should be used for <em>H. pylori</em> visualization (nonsilver-based stains, silver-based stains, or immunohistochemical stains). It is frequently possible to identify <em>H. pylori</em> in standard H&amp;E preparations. However, the distribution of <em>H. pylori</em> in the stomach is variable, and the growth may be attenuated during treatment with proton pump inhibitors. When a low density of <em>H. pylori </em>and atrophic mucosal changes are combined, visualization of the organism becomes unreliable on H&amp;E alone. (See  <a class="medical medical_review" href="/d/html/31.html" rel="external">"Acute and chronic gastritis due to Helicobacter pylori", section on 'Histopathology'</a>.)</p><p></p><p class="bulletIndent1">Noninvasive testing for <em>H. pylori </em>with urea breath testing and stool antigen testing has high sensitivity and specificity for active <em>H. pylori </em>infection. (See  <a class="medical medical_review" href="/d/html/18.html" rel="external">"Indications and diagnostic tests for Helicobacter pylori infection in adults", section on 'Diagnostic tests'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunologic</strong> <strong>markers</strong> –<strong> </strong>In patients with evidence of early/evolving histologic features of autoimmune chronic atrophic gastritis, the presence of antibodies to intrinsic factor or parietal cells, in conjunction with an elevated fasting serum gastrin level, can support the diagnosis. (See  <a class="medical medical_review" href="/d/html/30.html" rel="external">"Metaplastic (chronic) atrophic gastritis", section on 'Histologic features of AMAG and EMAG'</a>.)</p><p></p><p class="headingAnchor" id="H86361287"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/16944.html" rel="external">"Patient education: Gastritis (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/15732.html" rel="external">"Patient education: Upper endoscopy (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/1992.html" rel="external">"Patient education: Upper endoscopy (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H10"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology</strong> – Gastric inflammatory disease can be broadly categorized into gastritis and gastropathy. Gastritis is predominantly an inflammatory process while gastropathy denotes gastric mucosal pathology with minimal to no inflammation. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology and classification</strong> – Gastritis is usually caused by infectious agents (most commonly, <em>H. pylori</em>) or is immune mediated, although in many cases the cause of the gastritis is unknown. There is no universally accepted classification of gastritis/gastropathy, although several classifications of gastritis and gastropathy have been proposed  (<a class="graphic graphic_table graphicRef91372" href="/d/graphic/91372.html" rel="external">table 1</a>). (See <a class="local">'Etiology and classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of gastritis is usually established on biopsy specimens from patients undergoing upper endoscopy for evaluation of often unrelated upper abdominal symptoms. Endoscopic features of gastritis include erythema, mucosal erosions, the absence of rugal folds, and the presence of visible vessels. Histologic findings of gastritis can vary over a wide spectrum, ranging from epithelial hyperplasia with minimal inflammation (gastropathy) to extensive epithelial cell damage with infiltration by inflammatory cells. Accurate histologic assessment of gastritis and gastropathy depends upon optimizing the site and number of biopsy specimens. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Determining the underlying cause</strong> – The etiology of gastritis may be clear based on the clinical history and histopathologic examination. However, in other cases (often in mild gastritis), additional testing for <em>H. pylori</em> and autoimmune gastritis may be required. (See <a class="local">'Determining the etiology'</a> above.)</p><p></p><p class="headingAnchor" id="H26013992"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Beverly Dickson, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Dixon MF, Genta RM, Yardley JH, Correa P. Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter 1997; 2 Suppl 1:S17.</a></li><li><a class="nounderline abstract_t">Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991; 6:209.</a></li><li><a class="nounderline abstract_t">Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988; 83:504.</a></li><li><a class="nounderline abstract_t">Wyatt JI, Dixon MF. Chronic gastritis--a pathogenetic approach. J Pathol 1988; 154:113.</a></li><li><a class="nounderline abstract_t">Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161.</a></li><li><a class="nounderline abstract_t">Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology 1995; 108:917.</a></li><li><a class="nounderline abstract_t">Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56:631.</a></li><li><a class="nounderline abstract_t">Rugge M, Fassan M, Pizzi M, et al. Autoimmune gastritis: histology phenotype and OLGA staging. Aliment Pharmacol Ther 2012; 35:1460.</a></li><li><a class="nounderline abstract_t">Marcos-Pinto R, Carneiro F, Dinis-Ribeiro M, et al. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment Pharmacol Ther 2012; 35:1451.</a></li><li><a class="nounderline abstract_t">Rugge M, Correa P, Di Mario F, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008; 40:650.</a></li><li><a class="nounderline abstract_t">Park JY, Lam-Himlin D, Vemulapalli R. Review of autoimmune metaplastic atrophic gastritis. Gastrointest Endosc 2013; 77:284.</a></li><li><a class="nounderline abstract_t">Isajevs S, Liepniece-Karele I, Janciauskas D, et al. Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch 2014; 464:403.</a></li><li><a class="nounderline abstract_t">Autoimmune gastritis. Nat Rev Dis Primers 2020; 6:57.</a></li><li><a class="nounderline abstract_t">Laine L, Cohen H, Sloane R, et al. Interobserver agreement and predictive value of endoscopic findings for H. pylori and gastritis in normal volunteers. Gastrointest Endosc 1995; 42:420.</a></li><li><a class="nounderline abstract_t">Redéen S, Petersson F, Jönsson KA, Borch K. Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample. Endoscopy 2003; 35:946.</a></li><li><a class="nounderline abstract_t">Owen DA. Gastritis and carditis. Mod Pathol 2003; 16:325.</a></li><li><a class="nounderline abstract_t">Sepulveda AR, Patil M. Practical approach to the pathologic diagnosis of gastritis. Arch Pathol Lab Med 2008; 132:1586.</a></li></ol></div><div id="topicVersionRevision">Topic 29 Version 18.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9432349" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1912431" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The Sydney System: histological division.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3364410" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Chronic gastritis: a clinico-pathological classification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3280764" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Chronic gastritis--a pathogenetic approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8827022" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7875496" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17142647" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Gastritis staging in clinical practice: the OLGA staging system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22519568" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Autoimmune gastritis: histology phenotype and OLGA staging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22548492" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18424244" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : OLGA staging for gastritis: a tutorial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23199649" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Review of autoimmune metaplastic atrophic gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24477629" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32647157" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Autoimmune gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8566631" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Interobserver agreement and predictive value of endoscopic findings for H. pylori and gastritis in normal volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14606018" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12692198" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Gastritis and carditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18834216" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Practical approach to the pathologic diagnosis of gastritis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
